COMPLERA 200 mg/1
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate · TABLET, FILM COATED · Gilead Sciences, Inc.
COMPLERA is a tablet, film coated containing emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate at 200 mg/1, taken oral. Manufactured by Gilead Sciences, Inc..
Key Facts
- Brand Name
- COMPLERA
- Generic Name
- emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
- NDC Code (Product)
61958-1101- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA202123
- Drug Class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 08/10/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is COMPLERA used for?
COMPLERA contains emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is COMPLERA a controlled substance?
COMPLERA is not classified as a controlled substance by the DEA.
What is the generic name for COMPLERA?
The generic name for COMPLERA is emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate. There are no other listed brand versions of emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate.
What is the NDC code for COMPLERA 200 mg/1?
The NDC (National Drug Code) for COMPLERA 200 mg/1 is 61958-1101, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)